NCT06313060

Brief Summary

Objectives: To evaluate the efficacy of the administration of carbonated beverages in the resolution of dietary esophageal impaction, and to identify subgroups in which their effectiveness may be different: patients with/without esophageal diseases, with/without a history of impaction. Methods: A clinical trial was conducted randomizing consecutive patients with a clinical diagnosis of dietary esophageal impaction to receive 200cc of carbonated drink or not at all, excluding patients with a previous diagnosis of non-esophageal stenosis that could not be overcome with a gastroscope and suspected impaction by non-alimentary foreign bodies, spines or bones. Subsequently, an endoscopic evaluation will be carried out in all cases, checking the presence or absence of a foreign body and removing it if necessary, as well as assessing and recording the possible underlying esophageal pathology. A telephone follow-up will be carried out after 7 days, recording possible adverse events.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
354

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 2, 2024

Completed
13 days until next milestone

First Posted

Study publicly available on registry

March 15, 2024

Completed
Same day until next milestone

Study Start

First participant enrolled

March 15, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2025

Completed
Last Updated

March 13, 2025

Status Verified

March 1, 2025

Enrollment Period

10 months

First QC Date

March 2, 2024

Last Update Submit

March 10, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Efficacy of carbonated beverage for disimpaction

    Number of patients with esophageal impaction resolved with the carbonated beverage

    3 years

Study Arms (2)

Intervention group

EXPERIMENTAL

200 ml of Coca-Cola will be administered and must be ingested within a maximum of 10 minutes

Dietary Supplement: Coca-cola

Control group

NO INTERVENTION

will not receive any type of medication or drink

Interventions

Coca-colaDIETARY_SUPPLEMENT

200 ml of Coca-Cola will be administered and must be ingested within a maximum of 10 minutes

Intervention group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who come to the Emergency Department with a clinical diagnosis of esophageal impaction due to food bolus (determined by at least one of the following symptoms: sialorrhea, inability to swallow or cervical or retrosternal foreign body sensation) that requires endoscopic extraction.

You may not qualify if:

  • Pregnancy.
  • Benign or malignant esophageal stricture that cannot be overcome with a conventional gastroscope.
  • Patients with intraesophageal prostheses
  • Non-food foreign body (includes fish bones or bones)
  • Ingestion of some type of carbonated beverage after impaction.
  • Contraindication for the administration of carbonated drink (Cola-Cola) due to allergy or intolerance to any of its components.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Manuel Perez-Miranda

Valladolid, Spain

Location

MeSH Terms

Conditions

Esophageal Diseases

Condition Hierarchy (Ancestors)

Gastrointestinal DiseasesDigestive System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized clinical trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 2, 2024

First Posted

March 15, 2024

Study Start

March 15, 2024

Primary Completion

January 1, 2025

Study Completion

January 1, 2025

Last Updated

March 13, 2025

Record last verified: 2025-03

Data Sharing

IPD Sharing
Will not share

Locations